The Gross Margin of Kyorin Pharmaceutical Co Ltd (4569.T) is 43.01%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-03-31 | 43.01% |
2023-03-31 | 44.29% |
2022-03-31 | 46.85% |
2021-03-31 | 50.17% |
2020-03-31 | 51.86% |
2019-03-31 | 50.53% |
2018-03-31 | 55.65% |
2017-03-31 | 55.93% |
2016-03-31 | 60.36% |
2015-03-31 | 58.81% |